Access to Sterile Syringes and Public Health Costs in New Jersey: Suggestions for Public Policy

November 1, 2003
Donald M. Scarry, J.D., Ph.D.
Commissioned by the Drug Policy Alliance

This report highlights the connections between New Jersey's restrictive distribution scheme for sterile syringes and the incidence of HIV/AIDS and Hepatitis C among injection drug users. The recommendation we offer in this report is simple and straightforward: Any steps New Jersey can take to increase access to sterile syringes should be immediately incorporated into a strong, aggressive public health strategy to combat injection drug use.